Celator Pharma Cmn (CPXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 18,196 | 17,915 | 14,614 | 8,000 | 15,149 |
| Operating Income | -18,196 | -17,915 | -14,614 | -8,000 | -15,149 |
| Interest Expense | 1,793 | 904 | 147 | 4,264 | 79 |
| Other Income | -11 | -21 | -7,495 | -9 | 94 |
| Pre-tax Income | -20,000 | -18,840 | -22,257 | -12,272 | -15,135 |
| Income Tax | -684 | -1,937 | -1,412 | -1,364 | -975 |
| Net Income Continuous | -19,315 | -16,903 | -20,844 | -10,909 | -14,160 |
| Net Income | $-19,315 | $-16,903 | $-20,844 | $-10,909 | $-14,160 |
| EPS Basic Total Ops | -0.57 | -0.62 | -0.95 | -0.88 | -1.81 |
| EPS Basic Continuous Ops | -0.57 | -0.62 | -0.95 | -0.88 | -1.81 |
| EPS Diluted Total Ops | -0.57 | -0.62 | -0.95 | -0.88 | -1.81 |
| EPS Diluted Continuous Ops | -0.57 | -0.62 | -0.95 | -0.88 | -1.81 |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.62 | -0.73 | -1.30 | N/A |
| EBITDA(a) | $-17,998 | $-17,719 | $-14,416 | $-7,588 | $-14,707 |